All lobbying filings
Thorn Run Partners
Thorn Run Partners filed a Q3 report for Exelixis on October 19, 2026, reporting $60,000 in lobbying income.
Lobbying for Exelixis · Genomics-based drug discovery company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
California
Lobbyists on this filing
1
-
CATHERINE FINLEYPreviously held: Staff Director, Senate Special Aging Committee; Senior Health Policy Advisor, Sen. Smith; Legislative Asst, Sen. Snowe
Government bodies contacted
2
Lobbying activity
2
Policies related to creating incentives for innovation in the life sciences.
Tracking implementation of prescription drug pricing policies included as part of the Inflation Reduction Act (IRA).